文献

J-GLOBAL ID：201802249105857761   整理番号：18A0987121

FLT3-ITD陽性急性骨髄性白血病の小児のためのリスク層別化治療:JPLSG AML-05試験からの結果

Risk-stratified therapy for children with FLT3-ITD-positive acute myeloid leukemia: results from the JPLSG AML-05 study

著者 (26件)： SHIMADA Akira (Okayama Univ. Hospital, Okayama, JPN) ,  SHIMADA Akira (National Hospital Organization Nagoya Medical Center, Nagoya, JPN) ,  IIJIMA-YAMASHITA Yuka (National Hospital Organization Nagoya Medical Center, Nagoya, JPN) ,  TAWA Akio (National Hospital Organization Osaka Medical Center, Osaka, JPN) ,  TOMIZAWA Daisuke (National Center for Child Health and Dev., Tokyo, JPN) ,  YAMADA Miho (National Hospital Organization Nagoya Medical Center, Nagoya, JPN) ,  NORIO Shiba (Yokohama City Univ., Yokohama, JPN) ,  WATANABE Tomoyuki (Aichi Gakuin Univ., Aichi, JPN) ,  TAGA Takashi (Shiga Medical Univ., Shiga, JPN) ,  IWAMOTO Shotaro (Mie Univ., Mie, JPN) ,  TERUI Kiminori (Hirosaki Univ., Aomori, JPN) ,  MORITAKE Hiroshi (Miyazaki Univ., Miyazaki, JPN) ,  KINOSHITA Akitoshi (St. Marianna Univ., Kanagawa, JPN) ,  TAKAHASHI Hiroyuki (Toho Univ. Omori Medical Center, Tokyo, JPN) ,  NAKAYAMA Hideki (Kyushu Cancer Center, Fukuoka, JPN) ,  KOH Katsuyoshi (Saitama Children’s Medical Center, Saitama, JPN) ,  GOTO Hiroaki (Kanagawa Children’s Medical Center, Kanagawa, JPN) ,  KOSAKA Yoshiyuki (Kobe Children’s Medical Center, Kobe, JPN) ,  SAITO Akiko Moriya (National Hospital Organization Nagoya Medical Center, Nagoya, JPN) ,  KIYOKAWA Nobutaka (National Center for Child Health and Dev., Tokyo, JPN) ,  HORIBE Keizo (National Hospital Organization Nagoya Medical Center, Nagoya, JPN) ,  HARA Yusuke (Gunma Univ., Maebashi, JPN) ,  OKI Kentaro (National Center for Child Health and Dev., Tokyo, JPN) ,  HAYASHI Yasuhide (Gunma Children’s Medical Center, Shibukawa, JPN) ,  TANAKA Shiro (Kyoto Univ., Kyoto, JPN) ,  ADACHI Souichi (Kyoto Univ., Kyoto, JPN)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 107  号： 5  ページ： 586-595  発行年： 2018年05月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： ・FMS様チロシンキナーゼ3(AML<sup>FLT-ITD...

シソーラス用語： *急性骨髄性白血病 ,...
準シソーラス用語： 遺伝子変異 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0987121&from=J-GLOBAL&jstjournalNo=F0888A") }}

分類 (1件)： 血液疾患の治療一般  (GK05010E)

引用文献 (26件)：

• Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, et al. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood. 2001;97:89-94.
• Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L, et al. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood. 2003;102:2387-94.
• Staffas A, Kanduri M, Hovland R, Rosenquist R, Ommen HB, Abrahamsson J, et al. Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Blood. 2011;118:5905-13.
• Shimada A, Taki T, Tabuchi K, Taketani T, Hanada R, Tawa A, et al. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group. Pediatr Blood Cancer. 2008;50:264-9.
• Meshinchi S, Alonzo TA, Stirewalt DL, Zwaan M, Zimmerman M, Reinhardt D, et al. Clinical implications of FLT3 mutations in pediatric AML. Blood. 2006;108:3654-61.

タイトルに関連する用語 (7件)： flt3 ,  急性骨髄性白血病 ,  小児 ,  リスク層別化 ,  治療 ,  AML ,  試験